TARA · Protara Therapeutics, Inc.

$4.08 -0.01 (-0.24%) At close · Jul 22

Market Cap

$226.50M

56.20M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed	Seller	Relationship	Shares	Market Value	Approx. Sale	Broker
2026-06-29	JESSE SHEFFERMAN	Officer, Director	215,687	$882,009	2026-06-29	Morgan Stanley Smith Barney LLC Executive Financial Services
2026-04-23	Baker Brothers Life Sciences, L.P.	Former Affiliate	300,176	$1,605,942	2026-04-23	Jefferies LLC
2026-04-23	667, L.P.	Former Affiliate	24,802	$132,691	2026-04-23	Jefferies LLC
2026-04-01	Zummo Jacqueline	Officer	23,732	$124,826	2026-04-01	THE CHARLES SCHWAB CORPORATION
2026-03-06	Baker Brothers Life Sciences, L.P.	Former Affiliate	461,723	$2,701,080	2026-03-06	Canaccord Genuity LLC
2026-03-06	667, L.P.	Former Affiliate	38,277	$223,920	2026-03-06	Canaccord Genuity LLC
2026-03-04	667, L.P.	Former Affiliate	35,173	$220,151	2026-03-04	Canaccord Genuity LLC
2026-03-04	Baker Brothers Life Sciences, L.P.	Former Affiliate	424,125	$2,654,641	2026-03-04	Canaccord Genuity LLC
2026-02-25	Baker Brothers Life Sciences, L.P.	Former Affiliate	947,479	$5,501,316	2026-02-25	Canaccord Genuity LLC
2026-02-25	667, L.P.	Former Affiliate	78,716	$457,046	2026-02-25	Canaccord Genuity LLC
2026-02-24	Baker Brothers Life Sciences, L.P.	Former Affiliate	322,039	$1,944,922	2026-02-24	Canaccord Genuity LLC
2026-02-24	667, L.P.	Former Affiliate	26,755	$161,584	2026-02-24	Canaccord Genuity LLC
2025-03-26	Zummo Jacqueline	Officer	21,224	$96,569	2025-03-26	THE CHARLES SCHWAB CORPORATION

Showing 1–13 of 13 filings

Key facts CIK 1359931 CUSIP 74365U107 13F (30d) 10 filings 10 filers Visit website Investor relations